MA49794A - Composition utilisée dans le traitement prophylactique et thérapeutique de troubles de l'appareil cardiovasculaire - Google Patents

Composition utilisée dans le traitement prophylactique et thérapeutique de troubles de l'appareil cardiovasculaire

Info

Publication number
MA49794A
MA49794A MA049794A MA49794A MA49794A MA 49794 A MA49794 A MA 49794A MA 049794 A MA049794 A MA 049794A MA 49794 A MA49794 A MA 49794A MA 49794 A MA49794 A MA 49794A
Authority
MA
Morocco
Prior art keywords
prophylactic
disorders
composition used
therapeutic treatment
cardiovascular system
Prior art date
Application number
MA049794A
Other languages
English (en)
Inventor
Elisa Brilli
Andrea Lacorte
Germano Tarantino
Original Assignee
Pharmanutra S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmanutra S P A filed Critical Pharmanutra S P A
Publication of MA49794A publication Critical patent/MA49794A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/326—Foods, ingredients or supplements having a functional effect on health having effect on cardiovascular health
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/15—Inorganic Compounds
    • A23V2250/156—Mineral combination
    • A23V2250/1592—Iron
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/15—Inorganic Compounds
    • A23V2250/156—Mineral combination
    • A23V2250/161—Magnesium
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/70—Vitamins
    • A23V2250/714—Vitamin K
    • A23V2250/7144—Vitamin K2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA049794A 2017-07-26 2018-07-26 Composition utilisée dans le traitement prophylactique et thérapeutique de troubles de l'appareil cardiovasculaire MA49794A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102017000085412A IT201700085412A1 (it) 2017-07-26 2017-07-26 Composizione per uso nella prevenzione e nel trattamento di patologie dell'apparato cardiovascolare

Publications (1)

Publication Number Publication Date
MA49794A true MA49794A (fr) 2020-06-03

Family

ID=60451085

Family Applications (1)

Application Number Title Priority Date Filing Date
MA049794A MA49794A (fr) 2017-07-26 2018-07-26 Composition utilisée dans le traitement prophylactique et thérapeutique de troubles de l'appareil cardiovasculaire

Country Status (18)

Country Link
US (1) US20200206157A1 (fr)
EP (1) EP3657963A1 (fr)
JP (2) JP2020528888A (fr)
KR (1) KR20200032691A (fr)
CN (1) CN111031813A (fr)
BR (1) BR112020000902B1 (fr)
CA (1) CA3070659A1 (fr)
CL (1) CL2020000170A1 (fr)
CO (1) CO2020000526A2 (fr)
EA (1) EA202090069A1 (fr)
IL (1) IL272138B2 (fr)
IT (1) IT201700085412A1 (fr)
JO (1) JOP20200012A1 (fr)
MA (1) MA49794A (fr)
MX (1) MX2020000806A (fr)
PH (1) PH12020550031A1 (fr)
WO (1) WO2019021232A1 (fr)
ZA (1) ZA202000461B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11202012070YA (en) 2018-06-08 2021-01-28 Epizon Pharma Inc Methods and compositions for preventing or treating tissue calcification
JP2021527129A (ja) 2018-06-08 2021-10-11 エピゾン・ファーマ・インコーポレイテッドＥｐｉｚｏｎ Ｐｈａｒｍａ， Ｉｎｃ． カルシフィラキシスを予防または治療するための方法および組成物
WO2023232643A1 (fr) 2022-05-31 2023-12-07 Region Syddanmark Vitamine k2 destinée à être utilisée dans le traitement de la calcification des artères coronaires

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3860849B2 (ja) * 1994-04-28 2006-12-20 エーザイ・アール・アンド・ディー・マネジメント株式会社 抗動脈硬化治療剤
WO1996039053A2 (fr) * 1995-06-06 1996-12-12 Campbell Soup Company Complements alimentaires a base de mineraux pour repas dietetique
US6361800B1 (en) * 2000-04-13 2002-03-26 Cooper Concepts, Inc. Multi-vitamin and mineral supplement
GB0220182D0 (en) * 2002-08-30 2002-10-09 Cardiovascular Res Inst Maastr Organic compounds
AU2004287440A1 (en) * 2003-10-28 2005-05-19 Emory University Dialysates and methods and systems related thereto
US20050281888A1 (en) * 2004-06-16 2005-12-22 Chandra Ranjit K Nutritional supplement for infants
US20060134226A1 (en) * 2004-11-16 2006-06-22 Todd Leonard Compositions useful to treat ocular neovascular diseases and macular degeneration
DK1973552T3 (en) * 2005-12-23 2017-08-07 Ajay Gupta Parenteral nutritional composition containing iron
CN101374416A (zh) * 2006-01-30 2009-02-25 环亚有限公司 逆转、防止、延迟或稳定软组织钙化的方法
US20100021573A1 (en) * 2008-07-22 2010-01-28 Michael J Gonzalez Compositions and methods for the prevention of cardiovascular disease
JPWO2010073642A1 (ja) * 2008-12-25 2012-06-07 有限会社 アイ・ビー・イー 生物活性剤、医薬、化粧品、鮮度保持剤、および植物および動物の発育促進剤
CN103687495A (zh) * 2011-05-20 2014-03-26 弗里斯兰品牌有限公司 包含维生素k2的组合物
ITMI20121350A1 (it) * 2012-07-31 2014-02-01 Alesco Srl Composizione solido a base di ferro per uso nelle condizioni di deficienza di ferro.
EP2886129A1 (fr) * 2013-12-20 2015-06-24 VitaK B.V. Prévention et action contraire de risque de thrombose induite par le régime alimentaire
EP3258924A2 (fr) * 2015-02-20 2017-12-27 VitaK B.V. Statut en vitamine k et fonction capillaire

Also Published As

Publication number Publication date
PH12020550031A1 (en) 2021-02-08
IL272138A (en) 2020-03-31
CA3070659A1 (fr) 2019-01-31
JOP20200012A1 (ar) 2020-01-26
US20200206157A1 (en) 2020-07-02
WO2019021232A1 (fr) 2019-01-31
JP2020528888A (ja) 2020-10-01
IL272138B2 (en) 2023-09-01
IL272138B1 (en) 2023-05-01
IT201700085412A1 (it) 2019-01-26
ZA202000461B (en) 2021-03-31
CO2020000526A2 (es) 2020-02-18
BR112020000902A2 (pt) 2020-07-21
EA202090069A1 (ru) 2020-04-10
EP3657963A1 (fr) 2020-06-03
JP2023090869A (ja) 2023-06-29
CL2020000170A1 (es) 2020-10-30
CN111031813A (zh) 2020-04-17
MX2020000806A (es) 2020-08-17
BR112020000902B1 (pt) 2024-03-12
KR20200032691A (ko) 2020-03-26

Similar Documents

Publication Publication Date Title
MA50417A (fr) Procédés d'utilisation d'inhibiteurs de l'ehmt2 dans le traitement ou la prévention de troubles du sang
MA51200A (fr) Nouveaux composés et compositions pharmaceutiques associées pour le traitement de maladies
MA45481A (fr) Utilisation d'exosomes pour le traitement de maladies
MA46052A (fr) Modulateurs du récepteur hormonal pour le traitement d'états et de troubles métaboliques
MA45089A (fr) Utilisation d'indazoles 2-substitués pour le traitement et la prophylaxie de maladies auto-immunes
FR3032353B1 (fr) Composition pharmaceutique et dispositif pour le traitement de la douleur
MA49069A (fr) Procédés et compositions pour le traitement d'apnée du sommeil
MA47688A (fr) Compositions utiles dans le traitement de l'amyotrophie spinale
MA50849A (fr) Substances et procédés pour le traitement d'hémoglobinopathies
MA50763A (fr) Compositions d'acides aminés et méthodés de traitement de maladies et troubles musculaires
MA49368A (fr) Imidazopyrimidines à substitution diazabicyclique et leur utilisation pour traiter des maladies des voies respiratoires
MA43982A (fr) Anticorps anti-tnf, compositions, méthodes et utilisation pour le traitement ou la prévention du diabète de type 1
MA41996A (fr) Utilisation de triméthazine dans la préparation de médicaments pour la prévention et le traitement de maladies hépatiques
MA47069A (fr) Formes pharmaceutiques contenant des inhibiteurs des canaux task-1 et task-3 et leur utilisation pour le traitement de troubles respiratoires
MA44762A (fr) Sémaglutide utilisé dans le traitement de maladies cardiovasculaires
MA51056A (fr) Compositions et méthodes pour le traitement d'affections métaboliques
MA49794A (fr) Composition utilisée dans le traitement prophylactique et thérapeutique de troubles de l'appareil cardiovasculaire
MA44413A (fr) Composition pharmaceutique utilisée pour le traitement thérapeutique du cancer et ses complications
MA47074A (fr) Formes pharmaceutiques comprenant des inhibiteurs de canaux de task-1 et task-3 et leur utilisation pour le traitement des troubles respiratoires
MA52971A (fr) Compositions et procédés pour le traitement de l'infiltration de graisse dans le muscle
MA50233A (fr) Mic-1 et glp-1 destinés à être utilisés dans le traitement de l'obésité
MA50905A (fr) Composés et compositions pharmaceutiques de ceux-ci destinés à être utilisés dans le traitement de maladies fibrotiques
HK1250629A1 (zh) 用於治療人乳頭狀瘤病毒皮膚感染的含乙酰水楊酸的組合物和醫療裝置
MA56392A (fr) Dérivés de 2h-indazole et leur utilisation dans le traitement de maladies
MA41629A (fr) Compositions et méthodes d'utilisation de l'hormone anti-müllérienne pour le traitement de l'infertilité